Abdominal Aortic Aneurysm clinical trials at UCSF
3 in progress, 2 open to eligible people
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
open to eligible people ages 18 years and up
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
San Francisco, California and other locations
Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm
open to eligible people ages 18 years and up
To collect and analyze clinical follow-up data which can be used to assess the safety, efficacy, and durability of endovascular AAA repair with Zenith and Chuter-Gianturco stent-grafts.
San Francisco, California and other locations
Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study
Sorry, not accepting new patients
The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.
San Francisco, California and other locations
Our lead scientists for Abdominal Aortic Aneurysm research studies include Joseph H Rapp, MD Warren Gasper.
Last updated: